Nattokinase <-> PAI-1
- How Nattokinase does its magic (2017): Inhibition of PAI-1.
- Elevated PAI-1 predicts adverse outcomes in many conditions - MI, stroke, cancer, diabetes, pregnancy complications. It is considered a promising biomarker linking thrombosis, inflammation, metabolic disorders, and aging (2010).
- People who genetically doesn’t make too much PAI-1 live on average 7 yrs longer (2017).
- Metabolic Syndrome is associated with an overproduction of PAI-1 (2006).
- Inhibiting PAI-1 significantly helps with fatty liver and dyslipidemia. Activates FGF21 5-fold — a longevity molecule. And reduces PCKS9 (2021).
- Giving natto bacteria to worms makes the worms live longer (2023).
- Several drugs are in the clinical pipeline to inhibit PAI-1, but high dose nattokinase might be the safest option today.
Many more references and details in the blog post.







